Abstract
Objective
This study evaluated the frequency of hepatitis B virus (HBV) and hepatitis C virus (HCV) infection and the associated horizontal risk factors in children being screened for viral hepatitis in Lahore, Pakistan.
Methods
Children aged 15 years or younger who were brought to a specialized outpatient viral hepatitis clinic affiliated with a tertiary hospital in Lahore, Pakistan, for viral hepatitis screening from March 2017 to March 2018 were enrolled. Children were screened for HBV and HCV infection by enzyme-linked immunosorbent assay; if results were positive, HBV and HCV concentrations were quantitatively assayed by polymerase chain reaction. Children positive for HBV or HCV infection were matched with 100 controls of the same age and sex. All subjects completed a questionnaire on viral infection and its associated risk factors.
Results
During the study period, 3500 children living in the Punjab Province of Pakistan were screened for HBV and HCV infection. Of these children, 28 (0.8%) were positive for HBV and 66 (1.88%) were positive for HCV. A comparison of the 94 (2.68%) children positive for HBV or HCV with 100 controls identified several risk factors associated with infection. Unexpectedly, ten (35.7%) of the 28 HBV-positive children were born of HBV-negative mothers and had been fully vaccinated for HBV during infancy.
Conclusion
The frequency of HCV infection was higher than that of HBV infection among Pakistani children aged ≤15 years. Several horizontal risk factors were found to cause viral hepatitis. Several children born of HBV-negative mothers and vaccinated for HBV during infancy later developed HBV infection.
Keywords: children, hepatitis c virus, hepatitis b virus, frequency, risk factors
Introduction
Hepatitis B virus (HBV) and hepatitis C (HCV) virus are the most common viruses resulting in chronic liver disease (CLD) [1]. Of the approximately 170 million people worldwide infected with HCV, 71 million progress to have CLD, putting them at risk of cirrhosis and hepatocellular carcinoma (HCC) [2-3]. HCV-associated CLD remains a major indication for liver transplantation [4].
Almost 360 million people worldwide, or approximately 6% of the global population, are chronically infected with HBV [5]. The incidence of HBV infection has decreased after the introduction of international vaccination schemes and meticulous screening of people donating blood. However, large numbers of children are infected and will require long-term care in outpatient clinics. Despite the generally benign nature of chronic hepatitis B in children, studies have estimated that 1% to 5% develop cirrhosis and 2% to 5% develop HCC during childhood [6].
Horizontal transmission, especially in children, remains an important cause of HBV and HCV infection in developing countries, including Pakistan. Both viruses are blood-borne and spread by unsafe blood transfusion and the use of non-sterilized syringes and surgical equipment. Few studies to date, however, have assessed the incidence of HBV and HCV infection in children. The prevalence of HCV infection in the Punjab Province of Pakistan remains very high. The present study, therefore, assessed the frequency and risk factors for viral hepatitis in Punjabi children being screened at a specialized urban viral hepatitis clinic affiliated with the Pakistan Kidney and Liver Institute and Research Center, a tertiary hospital in Lahore, Pakistan.
Materials and methods
Children aged ≤15 years living in Punjab Province, the second largest province in Pakistan, screened for viral hepatitis at the Hepatitis Prevention and Treatment Clinic (HPTC) in Lahore, Pakistan, from March 2017 to March 2018 were recruited. Most subjects lived in Lahore, the largest city in Punjab Province, but others lived in various geographic regions throughout this province (Figure 1).
Figure 1. Geographical distribution of viral and non-viral hepatitis in children screened at HPTC, Lahore, Pakistan.
HPTC, Hepatitis Prevention and Treatment Clinic
All children were otherwise healthy and were screened as a precautionary measure or due to a family member being infected with HBV or HCV.
Blood was drawn from each subject, and serum was prepared. Subjects were initially tested for HBV and HCV infection by enzyme-linked immunosorbent assays (ELISA) for hepatitis B surface antigen (HBsAg) and anti-HCV antibody. If ELISA results were positive, HBV and HCV concentrations were quantitatively determined by polymerase chain reaction. Children positive for HBV or HCV infection were matched 1:1 with control, randomly selected children of the same age and sex who had not had any significant medical conditions.
All subjects completed a questionnaire on viral incidence and associated risk factors, as well as questions evaluating maternal HBV and HCV infection. Data were analyzed using IBM SPSS Statistics for Windows, Version 22.0. (Armonk, NY: IBM Corp.). Associations between dependent and independent variables were assessed by chi-square tests. Data normality was assessed using the Kolmogorov test and regression analysis. The p-values of less than 0.05 were considered statistically significant. Multivariable logistic regression analysis was performed, with results presented as odds ratios (ORs) and 95% confidence intervals (CIs).
Results
This comparative, cross-sectional study analyzed the frequency of HBV and HCV infection and risk factors associated with infection in Punjabi children aged ≤15 years. Of the 3500 children screened, 94 (2.68%) were positive for HBV and HCV, including 28 (0.8%) positive for HBV and 66 (1.88%) positive for HCV. The mean age of these 94 infected subjects was 10.1 ± 3.9 years, whereas the mean age of the 100 matched controls was 9.6 ± 3.7 years. Of the 94 positive subjects, 13 (13.8%) were younger than age 5, 29 (30.9%) were aged five to 10 years, and 52 (55.3%) were aged 10 to 15 years. Of the 100 control subjects, eight (8%) were younger than age five, 41 (41%) were aged five to 10 years, and 51 (51%) were aged 10 to 15 years.
Of the subjects assessed, 4% of girls and 10% of boys were HBV-infected, whereas 12.5% of girls and 20.5% of boys were HCV-infected. We found that 89% of HBV-infected children and 79% of HCV-infected children had a family history of infection. Univariable analysis showed that a family history of HBV infection and surgical procedures in government hospitals were significant risk factors for HBV infection (P-value <0.001 each). Receipt of blood transfusions, exposure to dental and surgical procedures at public hospitals, and a family history of hepatitis were significantly associated with HCV infection (P-values <0.05 each). Variables with P-values <0.20 were included in the multivariable logistic model. Multivariable logistic regression analysis identified two risk factors significantly associated risk with HBV infection: having an HBV-infected mother and circumcision by a barber (Table 1).
Table 1. Multivariable logistic regression of risk factors in matched actual case/control groups of children screened for HBV.
HBV, Hepatitis B virus; HCV, Hepatitis C virus
| Variable | Status | Cases/Controls | Odds Ratio | 95% Confidence Interval | P-value |
| Vaccination Status | Yes | 24/26 | 0.46 | 0.07-2.75 | 0.39 |
| No | 4/2 | - | |||
| Toothbrush Sharing | Yes | 2/15 | 0.90 | 0.6-1.2 | 0.49 |
| No | 26/13 | - | - | ||
| Mother HBV Status | Positive | 5/1 | 5.8 | 0.3-53 | 0.11 |
| Negative | 23/27 | - | - | ||
| Maternal HCV Status | Positive | 12/11 | 1.15 | 0.39-3.3 | 0.78 |
| Negative | 16/17 | - | - | ||
| Circumcision | Home | 18/10 | 1.53 | 0.3-1.81 | 0.003 |
| Hospital | 0/4 | - | - | ||
| N/A | 10/14 | - | - |
Multivariable logistic regression analysis identified several risk factors independently associated with HCV infection: male sex, receipt of intravenous injections, hospital admissions, exposure to surgical and dental procedures, circumcision by barbers, and having an HCV-infected mother (Table 2).
Table 2. Multivariable logistic regression for risk factors in matched actual case/control groups of children screened for HCV.
HCV, Hepatitis C virus
| Variable | Status | Cases/Controls | Odds Ratio | 95% Confidence Interval | P-value |
| Gender | Male | 43/31 | 1.14 | 0.8-2.3 | 0.019 |
| Female | 23/35 | - | - | ||
| Intravenous Injection | <5 injections | 11/14 | - | - | 0.53 |
| >5 injections | 55/52 | 1.3 | 0.5-2.9 | ||
| Exposure To Dental Procedure | Yes | 10/4 | 1.10 | 0.7-1.5 | 0.57 |
| No | 56/62 | - | - | ||
| Hospitalization Status | Yes | 26/13 | 1.33 | 0.8-2.0 | 0.01 |
| No | 40/53 | - | - | ||
| Exposure To Surgical Procedure | Yes | 10/2 | 1.14 | 0.7-1.6 | 0.04 |
| No | 56/64 | - | - | ||
| Exposure To Head Shave/Trim | Yes | 23/32 | 0.78 | 0.4-1.2 | 0.30 |
| No | 43/34 | - | - | ||
| Toothbrush Sharing | Yes | 6/9 | 0.94 | 0.6-1.3 | 0.78 |
| No | 60/57 | - | - | ||
| Maternal HCV Status | Positive | 34/30 | 1.12 | 0.6-1.8 | 0.62 |
| Negative | 32/36 | - | - | ||
| Circumcision | Home | 38/20 | 1.51 | 0.2-0.8 | 0.01 |
| Hospital | 0/11 | - | - | ||
| N/A | 28/35 | - | - |
Of the 28 children positive for HBV cases, 10 (35.7%) were born of HBV-negative mothers and received three doses of HBV vaccine as infants.
Discussion
HCV occurs in about 0.15% of children aged six to 11 years and 0.4% of those aged 12 to 19 years. A previous study performed by the Pakistan Medical and Research Council (PMRC) from mid-2007 to mid-2008 reported the prevalence of HBV and HCV in hospitalized children and those in outpatient clinics [7]. That study found that the incidence of infection varied in different parts of the country, with most infected patients being from Baluchistan and Sindh Provinces. Only 2.5% of recruited patients were positive for HBsAg, whereas 4.9% were positive for anti-HCV antibody, making the overall infection rate 7.4% [8]. Another study, involving 3533 Pakistani children, found that 65 (1.8%) were positive for HBsAg and 55 (1.6%) positive for anti-HCV antibody, making the overall infection rate 3.3% [9]. The main risk factor for HBV infection was the receipt of therapeutic injections. Another Pakistani study reported that the prevalence of HBsAg in pediatric populations was 2.4% (range 1.7-5.5%), whereas the prevalence of anti-HCV antibody was 2.1% (range 0.4-5.4%) [10]. The major risk factors for the transmission of HBV and HCV included the use of contaminated needles during medical care, drug abuse, and unsafe transfusion of blood and blood products.
A study in Bangladesh reported that the risk factors for HBV infection in children were surgical procedures, intravenous, and intramuscular injections, mothers positive for HBV infection, and unhygienic haircuts by barbers [11]. The risk factors for HCV transmission in Egyptian children included a positive family history of HCV infection, parenteral injections, blood transfusion, surgery, and hospitalization [12].
In comparison, our study of 3500 children showed that the frequency of combined HBV and HCV infection was 2.68%, including 0.8% infected with HBV and 1.88% infected with HCV. Risk factors significantly associated with HCV infection included male sex, intravenous injections, exposure to surgical operations and dental procedures, multiple hospitalizations, HCV-positive mothers, and circumcision by barbers. The significant risk factors associated with HBV infection were male sex, HBV-positive mothers, and circumcision by barbers.
Steps to curtail unwanted injections and the use of contaminated needles should be strongly encouraged. The proper sterilization surgical instruments and apparatus used in body piercing, along with pre-transfusion screening tests, are essential to avoid virus transmission [13-14]. A mass immunization policy may prevent HBV infection in Pakistani children. This policy should include the vaccination of infants aged 6 weeks, 10 weeks, and 14 weeks.
We found that 10 (35.7%) of the 28 HBV-positive children were born of HBV-negative mothers and had been fully vaccinated for HBV during infancy. These children did not have any other active health issues, suggesting that a faulty immunization technique or improper storage of vaccines may have led to HBV infection, despite their mothers being HBV-negative and receiving a vaccination themselves.
Due to a lack of resources, we were unable to measure the titer of the anti-hepatitis B surface (Anti-HBS) antibody or assess maternal infection. Fully vaccinated children with low antibody levels may require a booster dose if the level remains low despite being fully vaccinated. Administration of vaccine and hepatitis B immunoglobulin promptly after birth may enhance immune success rates to 90% and 98% in Hepatitis B e-Antigen (HBeAg)-positive and negative mothers, respectively [15-17].
The likelihood of maternal HCV transfer to a newborn is <5% [18-20]. However, it was not possible to determine the frequency of vertical transmission of the virus to the 66 HCV-positive children in this study because maternal HCV status was not known, and laboratory tests were not performed during early infancy.
Conclusions
The frequency of HCV infection is higher than that of HBV infection in Pakistani children, with viral hepatitis being due in part to unsafe medical practices. Some children of HBV-negative mothers who were vaccinated as infants were positive for HBV. National policies should be aligned with global recommendations.
The content published in Cureus is the result of clinical experience and/or research by independent individuals or organizations. Cureus is not responsible for the scientific accuracy or reliability of data or conclusions published herein. All content published within Cureus is intended only for educational, research and reference purposes. Additionally, articles published within Cureus should not be deemed a suitable substitute for the advice of a qualified health care professional. Do not disregard or avoid professional medical advice due to content published within Cureus.
The authors have declared that no competing interests exist.
Human Ethics
Consent was obtained by all participants in this study
Animal Ethics
Animal subjects: All authors have confirmed that this study did not involve animal subjects or tissue.
References
- 1.Impact of comorbidities on the severity of chronic hepatitis B at presentation. Sagnelli E, Stroffolini T, Mele A, Imparato M, Sagnelli C, Coppola N, Almasio PL. World J Gastroenterol. 2012;18:1616–1621. doi: 10.3748/wjg.v18.i14.1616. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Epidemiological study of hepatitis B and hepatitis C infections in Northeastern China and the beneficial effect of the vaccination strategy for hepatitis B: a cross-sectional study. Wang S, Tao Y, Tao Y, et al. BMC Public Health. 2018;18:1088. doi: 10.1186/s12889-018-5984-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.World Health Organization. Fact sheet on hepatitis C. [Feb;2020 ];https://www.who.int/news-room/fact-sheets/detail/hepatitis-c 2019). Accessed
- 4.Treatment of chronic hepatitis C with recombinant interferon alfa. Davis GL, Balart LA, Schiff ER, et al. N Engl J Med. 1989;321:1501–1156. doi: 10.1056/NEJM198911303212203. [DOI] [PubMed] [Google Scholar]
- 5.Hepatitis B infection: current concepts and future challenges. Nebbia G, Peppa D, Maini MK. QJM. 2012;105:109–113. doi: 10.1093/qjmed/hcr270. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Polaris Observatory Collaborators. Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study. Lancet Gastroenterol Hepatol. 2018;3:383–403. doi: 10.1016/S2468-1253(18)30056-6. [DOI] [PubMed] [Google Scholar]
- 7.Chronic hepatitis B in children and adolescents. Paganelli M, Stephenne X, Sokal EM. J Hepatol. 2012;57:885–896. doi: 10.1016/j.jhep.2012.03.036. [DOI] [PubMed] [Google Scholar]
- 8.Frequency of Hepatitis B and C in rural and periurban Sindh. Aziz S, Khanani R, Noorulain W, Rajper J. https://jpma.org.pk/article-details/2339. J Pak Med Assoc. 2010;60:853–857. [PubMed] [Google Scholar]
- 9.prevalence and risk factors associated with seropositivity among children in Karachi, Pakistan. Jafri W, Jafri N, Yakoob J, : Hepatitis B and C. BMC Infect Dis. 2006;6:101. doi: 10.1186/1471-2334-6-101. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Hepatitis B and hepatitis C in Pakistan: prevalence and risk factors. Ali SA, Donahue RMJ, Qureshi H, Vermund SH. Int J Infect Dis. 2009;13:9–19. doi: 10.1016/j.ijid.2008.06.019. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Risk factors of hepatitis B virus infection in children. Rukunuzzaman M, Afroza A. Mymensingh Med J. 2011;20:700–708. [PubMed] [Google Scholar]
- 12.Risk factors associated with high prevalence rates of hepatitis C infection in Egypt. Reker C, Islam KM. Int J Infect Dis. 2014;25:104–106. doi: 10.1016/j.ijid.2014.02.003. [DOI] [PubMed] [Google Scholar]
- 13.Unsafe injections in the developing world and transmission of blood borne pathogen: a review. Simonsen L, Kane A, Lloyd J, Zaffran M, Kane M. Bull World Health Organ. 1999;77:789–800. [PMC free article] [PubMed] [Google Scholar]
- 14.Injection use in two districts of Pakistan: Implications for disease prevention. Janjua NZ, Akhtar S, Hutin YJ. Int J Qual Health Care. 2005;17:401–408. doi: 10.1093/intqhc/mzi048. [DOI] [PubMed] [Google Scholar]
- 15.Effects of maternal screening and universal immunization to prevent mother-to infant transmission of HBV. Chen HL, Lin LH, Hu FC, et al. Gastroenterology. 2012;142:773–781. doi: 10.1053/j.gastro.2011.12.035. [DOI] [PubMed] [Google Scholar]
- 16.Hepatitis B vaccines: WHO position paper - World Health Organization. July. 2017. Wkly Epidemiol Rec. 2017;92:369–392. [Google Scholar]
- 17.Hepatitis B immunisation for newborn infants of hepatitis B surface antigen-positive mothers. Lee C, Gong Y, Brok J, Boxall EH, Gluud C. Cochrane Database Syst Rev. 2006;2:4790. doi: 10.1002/14651858.CD004790.pub2. [DOI] [PubMed] [Google Scholar]
- 18.Mother-to-infant transmission of hepatitis C virus. Yeung LT, King SM, Roberts EA. Hepatology. 2001;34:223–229. doi: 10.1053/jhep.2001.25885. [DOI] [PubMed] [Google Scholar]
- 19.European Paediatric Hepatitis C Virus Network: A significant sex-but not elective cesarean section-effect on mother-to-child transmission of hepatitis C virus infection. J Infect Dis. 2005;192:1872–1879. doi: 10.1086/497695. [DOI] [PubMed] [Google Scholar]
- 20.Hepatitis B and C. Karnsakul W, Schwarz KB. Pediatr Clin North Am. 2017;64:641–658. doi: 10.1016/j.pcl.2017.01.007. [DOI] [PMC free article] [PubMed] [Google Scholar]

